Taken together these studies indicate that PDE5 inhibition positively modulates tumor immunity by reducing the systemic immunosuppression, by priming an anti-tumor immune response, and by increasing the infiltration of effector T cells in the tumor. This evidence concerns the gene PDE5A and neoplasm.